The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy
- PMID: 21704181
- DOI: 10.1016/j.biocel.2011.06.006
The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy
Abstract
The ISG15/USP18 pathway modulates cellular functions and is important for the host innate immune response to chronic viral infections such as Hepatitis C Virus (HCV). Interferon stimulated gene 15 (ISG15) was the first ubiquitin-like protein modifier identified. As in ubiquitination, ISG15 conjugates to _target proteins (ISGylation) through the sequential enzymatic action of activating E1, conjugating E2, and ligating E3 enzymes. ISGylation modulates signal transduction pathways and host anti-viral response. The ISGylation process is reversible through the action of an ISG15 protease, USP18. Ubiquitin-like specific protease 18 (USP18) has functions that are both ISG15-dependent and ISG15-independent; the importance of the ISG15/USP18 pathway to chronic HCV infection is illustrated by the consistent finding of increased levels of ISG15 and USP18 in the liver tissue of patients who do not respond to interferon-based treatments. Mechanistically, HCV seems to exploit the ISG15/USP18 pathway to promote viral replication and evade innate anti-viral immune responses.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Protein interferon-stimulated gene 15 conjugation delays but does not overcome coronavirus proliferation in a model of fulminant hepatitis.J Virol. 2014 Jun;88(11):6195-204. doi: 10.1128/JVI.03801-13. Epub 2014 Mar 19. J Virol. 2014. PMID: 24648452 Free PMC article.
-
Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection.Nat Med. 2004 Dec;10(12):1374-8. doi: 10.1038/nm1133. Epub 2004 Nov 7. Nat Med. 2004. PMID: 15531891
-
Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon.Autophagy. 2015 Apr 3;11(4):617-28. doi: 10.1080/15548627.2015.1023982. Autophagy. 2015. PMID: 25906440 Free PMC article.
-
USP18-mediated protein deISGylation and its role in tuberculosis and other infectious diseases.Yi Chuan. 2023 Nov 20;45(11):998-1006. doi: 10.16288/j.yczz.23-185. Yi Chuan. 2023. PMID: 38764265 Review.
-
Interferon-stimulated gene 15 and the protein ISGylation system.J Interferon Cytokine Res. 2011 Jan;31(1):119-30. doi: 10.1089/jir.2010.0110. Epub 2010 Dec 29. J Interferon Cytokine Res. 2011. PMID: 21190487 Free PMC article. Review.
Cited by
-
Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.PLoS One. 2015 Jul 20;10(7):e0133800. doi: 10.1371/journal.pone.0133800. eCollection 2015. PLoS One. 2015. PMID: 26193702 Free PMC article.
-
Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.J Virol. 2016 May 27;90(12):5549-5560. doi: 10.1128/JVI.02557-15. Print 2016 Jun 15. J Virol. 2016. PMID: 27009955 Free PMC article.
-
A Four-Biomarker Blood Signature Discriminates Systemic Inflammation Due to Viral Infection Versus Other Etiologies.Sci Rep. 2017 Jun 6;7(1):2914. doi: 10.1038/s41598-017-02325-8. Sci Rep. 2017. PMID: 28588308 Free PMC article.
-
ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.Onco_target. 2016 Nov 8;7(45):74393-74409. doi: 10.18632/onco_target.11911. Onco_target. 2016. PMID: 27626310 Free PMC article. Review.
-
Interferon-stimulated gene 15 in hepatitis B-related liver diseases.Onco_target. 2016 Oct 18;7(42):67777-67787. doi: 10.18632/onco_target.11955. Onco_target. 2016. PMID: 27626177 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
